NCT Number: NCT05077098
Phase: Phase 1
Trial Summary: To evaluate the safety and tolerability of ADXS-504 and to determine the MT – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Mark Stein
Acronym:
Study of ADXS-504 Immunotherapy for Recurrent Prostate Cancer
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives